J. Kurniawan, A. D. Handayu, G. Aprilicia, D. R. Bahri, and I. Hasan, “Resistance-Associated Substitutions (RAS) and Clinical Factors as Determinants of Sofosbuvir-Daclatasvir Treatment Outcomes in Chronic Hepatitis C Patients”, Acta Med Indones, vol. 56, no. 4, p. 451, Jan. 2025.